Severe Combined Immunodeficiency (SCID)Symptoms, Doctors, Treatments, Advances & More
Severe Combined Immunodeficiency (SCID) Overview
Learn About Severe Combined Immunodeficiency (SCID)
- Severe combined immunodeficiency
- SCID
Andrew Gennery practices practicing medicine in Newcastle Upon Tyne, United Kingdom. Mr. Gennery is rated as an Elite expert by MediFind in the treatment of Severe Combined Immunodeficiency (SCID). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Primary Immunodeficiency (PID), Chronic Granulomatous Disease, Bone Marrow Transplant, and Heart Transplant.
Ansgar Schulz practices practicing medicine in Kassel, Germany. Schulz is rated as an Elite expert by MediFind in the treatment of Severe Combined Immunodeficiency (SCID). They are also highly rated in 31 other conditions, according to our data. Their clinical expertise encompasses Osteopetrosis, Severe Combined Immunodeficiency (SCID), CLN2 Disease, Bone Marrow Transplant, and Splenectomy.
St Petersburg Outpatient Care Center - University Of South Florida - Allergy & Immunology
Jolan Walter is a Pediatric Allergy and Immunologist practicing medicine in St Petersburg, Florida. Dr. Walter is rated as an Elite provider by MediFind in the treatment of Severe Combined Immunodeficiency (SCID). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Infantile Neutropenia, Common Variable Immune Deficiency, and X-Linked Severe Combined Immunodeficiency. Dr. Walter is board certified in American Board Of Allergy And Immunology. Dr. Walter is currently accepting new patients.
Summary: This is a Phase I/II non-randomized clinical trial of ex vivo hematopoietic stem cell (HSC) gene transfer treatment for X-linked severe combined immunodeficiency (XSCID, also known as SCID-X1) using a self-inactivating lentiviral vector incorporating additional features to improve safety and performance. The study will treat 35 patients with XSCID who are between 2 and 50 years of age and who have...
Summary: This study will examine the role of hereditary factors in different forms of severe combined immunodeficiency (SCID). Patients with immunodeficiencies may be eligible for this study. Candidates include: * Patients with diminished numbers of T cells or NK cells or both, or * Patients with normal T cell and NK cell numbers but diminished T cell, B cell, or NK cell function. Relatives of patients wil...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


